Home » Stocks » Colfax Corporation

Colfax Corporation (CFX)

Stock Price: $31.29 USD -0.40 (-1.26%)
Updated Oct 19, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 3.70B
Revenue (ttm) 3.17B
Net Income (ttm) -10.38M
Shares Out 118.39M
EPS (ttm) -0.08
PE Ratio n/a
Forward PE 16.53
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 19, 2020
Last Price $31.29
Previous Close $31.69
Change ($) -0.40
Change (%) -1.26%
Day's Open 31.78
Day's Range 31.17 - 32.03
Day's Volume 819,282
52-Week Range 12.23 - 39.30

More Stats

Market Cap 3.70B
Enterprise Value 6.02B
Earnings Date (est) Oct 29, 2020
Ex-Dividend Date n/a
Shares Outstanding 118.39M
Float 98.79M
EPS (basic) -0.07
EPS (diluted) -0.08
FCF / Share 0.94
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 3.01%
Payout Ratio n/a
Shares Short 18.68M
Short Ratio 19.53
Short % of Float 18.90%
Beta 1.89
PE Ratio n/a
Forward PE 16.53
P/FCF Ratio 33.26
PS Ratio 1.17
PB Ratio 1.14
Revenue 3.17B
Operating Income 168.05M
Net Income -10.38M
Free Cash Flow 111.38M
Net Cash -2.31B
Net Cash / Share -19.53
Gross Margin 44.44%
Operating Margin 5.30%
Profit Margin -0.30%
FCF Margin 3.51%
ROA 2.11%
ROE 1.32%
ROIC 2.40%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (18)

Buy 11
Overweight 1
Hold 5
Underweight 0
Sell 1

Analyst Consensus: Buy

Price Target

$39.25*
(25.44% upside)
Low
31.0
Current: $31.29
High
50.0
Target: 39.25
*Average 12-month price target from 16 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue3,3272,1931,9373,1863,4344,6244,2073,914693542
Revenue Growth51.73%13.2%-39.19%-7.24%-25.74%9.92%7.5%464.45%27.94%-
Gross Profit1,4017296729921,0721,4791,3061,152240191
Operating Income17015288.6723726641040614025.9134.37
Net Income-528140151128168392179-64.404.5616.22
Shares Outstanding11811712312312412410293.9843.6043.40
Earnings Per Share-3.891.161.221.041.343.021.54-0.920.100.37
EPS Growth--4.92%17.31%-22.39%-55.63%96.1%---72.97%-
Operating Cash Flow13122621924730438636217457.1561.97
Capital Expenditures-118-34.82-47.54-56.00-69.88-84.46-71.48-83.19-13.62-12.45
Free Cash Flow13.3319217119123430129190.8343.5349.51
Cash & Equivalents11077.1541220919730531148275.1160.54
Total Debt2,4481,1971,0611,2921,4181,5371,4871,72811282.50
Net Cash / Debt-2,339-1,120-649-1,083-1,220-1,231-1,176-1,246-36.41-21.96
Assets7,3876,6166,7106,3386,7337,2126,6016,1481,0891,022
Liabilities3,8973,1392,9823,2453,4763,8593,8603,992899806
Book Value3,4413,2703,5002,8973,0703,1472,5141,912189216
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Colfax Corporation
Country United States
Employees 15,000
CEO Matthew L. Trerotola

Stock Information

Ticker Symbol CFX
Stock Exchange New York Stock Exchange
Sector Industrials
Industry Specialty Industrial Machinery
Unique Identifier NYSE: CFX
IPO Date May 8, 2008

Description

Colfax Corporation operates as a diversified technology company worldwide. The company operates through two segments, Medical Technology and Fabrication Technology. The Medical Technology segment offers orthopedic solutions, including orthopedic devices and braces, reconstructive and surgical implants, footwear, bone growth stimulators, and software and services spanning the full continuum of patient care, as well as injury prevention, rehabilitation, pain management, and physical therapy under the Aircast, Chattanooga, CMF, Compex, DonJoy, ProCare, DJO Surgical, Dr. Comfort, Exos, and MotionMD brand names. Its products are used by orthopedic specialists, spine surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. This segment sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and direct and independent salespersons. The Fabrication Technology segment formulates, develops, manufactures, and supplies consumable products and equipment for use in cutting, joining, and automated welding of steels, aluminum, and other metals and metal alloys. It also provides welding consumables comprising electrodes, cored and solid wires, and fluxes using a range of specialty and other materials; and cutting consumables, such as electrodes, nozzles, and shields and tips under the ESAB brand name. This segment sells its products through independent distributors and direct sales to the infrastructure, wind power, marine, pipelines, mobile/off-highway equipment, oil, gas, and mining markets. Colfax Corporation was founded in 1860 and is headquartered in Annapolis Junction, Maryland.